NAM logo

Namwiwat Medical Corporation Stock Price

Symbol: SET:NAMMarket Cap: ฿2.9bCategory: Healthcare

NAM Share Price Performance

฿4.18
-0.78 (-15.73%)
฿4.18
-0.78 (-15.73%)
Price ฿4.18

NAM Community Narratives

There are no narratives available yet.

Recent NAM News & Updates

Namwiwat Medical Corporation Public Company Limited Key Details

฿1.6b

Revenue

฿1.1b

Cost of Revenue

฿560.7m

Gross Profit

฿380.7m

Other Expenses

฿180.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.26
Gross Margin
34.69%
Net Profit Margin
11.13%
Debt/Equity Ratio
16.4%

Namwiwat Medical Corporation Public Company Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Proven track record with adequate balance sheet.

3 Risks
2 Rewards

About NAM

Founded
1992
Employees
n/a
CEO
Viroj Chaiturdkiet
WebsiteView website
www.namwiwat.com

Namwiwat Medical Corporation Public Company Limited manufactures and distributes medical equipment in Thailand. The company provides medical supplies, disinfection services, medical equipment maintenance services, infectious waste services, and other medical services. It also offers equipment rental and contractual construction services. The company was formerly known as Namwiwat Engineering (1992) Company Limited and changed its name to Namwiwat Medical Corporation Public Company Limited. Namwiwat Medical Corporation Public Company Limited was founded in 1992 and is based in Samut Prakan, Thailand.

Market Insight

The market has already priced in a 25bps rate cut from the Fed next week like it’s a done deal. So this week, we’re zooming in on what’s really been going on in the bond market, and what it all means for dividend investors who want to maintain yield.
Continue reading

Thai Market Performance

  • 7 Days: 2.2%
  • 3 Months: 14.4%
  • 1 Year: -10.1%
  • Year to Date: -5.7%
The market has climbed 2.2% in the last 7 days, lead by the Information Technology sector with a gain of 5.9%. Longer term the market is actually down 10% over the past year. Looking forward, earnings are forecast to grow by 11% annually. Market details ›